RL

ROY LU

Partner at LongHash | ex-VC @Lightspeed | ex-PM @Amazon AWS | Stanford MBA

United States

Invests in

Locations:

  • Min Investment:

    $100,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $1,500,000.00

Work Experience

  • Partner

    2023

    Sourced and led investments into 0G, Ether.fi, Union, and Hyperbolic. LongHash Ventures values strong conviction and deep partnership with crypto-native visionaries. Select portfolio include Balancer, zkSync, Safe, Dodo, Coinshift. We specialize in helping protocol bootstrap ecosystems.

2022 - 2023

  • Partner

    2022 - 2023

    Hashkey Capital is a multi-stage venture capital firm investing in visionary blockchain founders. Since founding in 2015, Hashkey has invested in the most enduring blockchain companies including dydx, Blockdaemon, CoinList, FalconX, Cosmos, Ava Labs, and Dapper Labs. With over $1B AUM, HashKey invests across the stack (from layer0 to dapps) and verticals (from DeFi to zk).

2021 - 2022

  • MBA Investor

    2021 - 2022

    Venture Capital firm with $500M AUM Web3 Portfolio: Skolem Portfolio: DeepMind, Skype, Vicarious, Rigetti, Bestow, Rugged Robotics, Vintra, Rize

  • MBA Senior Product Manager - Technical

    2021 - 2021

  • MBA Growth Equity Investor

    2020 - 2020

    Venture Capital and Growth Equity firm in Silicon Valley, China, India, and Israel. $10.2Bn in AUM. Affirm, Blend, Carta, DoubleClick (NSDQ: DCLK), Docker, Grafana, Arctic Wolf, Snapchat (NYSE: SNAP), Pinduoduo (NSDQ: PDD), Ripple, and more.

2018 - 2020

  • Co-Founder and CEO

    2018 - 2020

    VC-backed startup. Mobile and enterprise AI to precision-serve and target your customers.

  • Fullstack Tech Lead

    2017 - 2018

    SaaS Unicorn. Sub-10 employee, full stack engineer, helped take Black Lake from 0 to 1. Backed by Lightspeed, Temasek, and GGV.

  • Accelerator Portfolio

    2017 - 2018

2015 - 2017

  • Software Section Supervisor

    2015 - 2017

    Fortune #24. Provided data storage and security solutions.

  • Biochemical Engineer

    2013 - 2014

    Fortune #153. Provided antibody therapeutics molecular testing.